BS Medicine Episode 624: PCSK9 Inhibitors: Cardiovascular prevention panacea or pricey pokes?

In this module of In the Clinic, the team discusses Diana Neer, a 64-year-old woman complaining of shoulder pain. To claim your CPD credits, click the link below and then select "Complete Activity."  https://cfpclearn.ca/podcast/itc61/

In this module of In the Clinic, the team discusses Diana Neer, a 64-year-old woman complaining of shoulder pain. To claim your CPD credits, click the link below and then select "Complete Activity."  https://cfpclearn.ca/podcast/itc60/

In episode 625, Mike K and James invite Danielle Perry and Tony Nickonchuk to the podcast to talk about the evidence around blood pressure measurement techniques. You might be surprised by what does and does not influence blood pressure measurements. Check out the podcast. Show Notes Tools For Practice Blood Pressure Measurement Technique: Meaningful mistakes or minor details? To claim your CPD credits, click the link below and then select "Claim Credits Now".   https://cfpclearn.ca/podcast/bs625/

In episode 624, James and Mike K invite Tony Nickonchuk to go over all the new evidence we have for the PCSK9 inhibitors. First, we discuss whether or not the evidence addresses the issue of primary versus secondary prevention. We then give you all the numbers and the context you need to allow you to discuss these with your patients. Show Notes Tools For Practice PCSK9 Inhibitors: Cardiovascular prevention panacea or pricey pokes? PEIP Conference Oct 16-17, 2026 To claim your CPD credits, click the link below and then select "Claim Credits Now".   https://cfpclearn.ca/podcast/bs624/

Le groupe d'intérêt des membres sur la santé des patients 2SLGBTQ+ a collaboré avec projet NUANCES, centre de soins en diversité sexuelle et de genre. Dre Judith Lajeunesse et Caroline Paquette de projet NUANCES présentent un cas clinique qui permettra aux médecins de famille de mieux comprendre leur rôle en appuyant les patients qui veulent discuter une transition de genre.

This podcast discusses two of the most common gender-affirming surgeries - vaginoplasty in a transfeminine patient and top surgery or mastectomy in a trans masculine patient. These are emotionally high stakes surgeries for our transgender and gender diverse patients. Family doctors have the knowledge and skills to provide routine postoperative care, and equally important, provide reassurance and a safe place for our patients to be heard.

In episode 623, Jamie and James invite Samantha Moe back again to talk about the never-ending debate as to what is the target for systolic blood pressure. We look at the evidence and then try to put it into a reasonable context because at best the evidence is always nuanced. But at least you will now know the numbers. To claim your CPD credits, click the link below and then select "Claim Credits Now".   https://cfpclearn.ca/podcast/bs-medicine-epis…-pressure-target/

In episode 622, Jamie and James invite Émélie Braschi back again to talk about if we should be using inhalers that combine corticosteroids and beta-agonists as rescue inhalers. We go over the best available evidence and then try to put the findings into context. To claim your CPD credits, click the link below and then select "Claim Credits Now".   https://cfpclearn.ca/podcast/bs-medicine-epis…haler-for-asthma/  

In this episode of In the Clinic, the team discusses Tina Mojsov, a 30-year-old woman who wants to lose weight.  To claim your CPD credits, click the link below and then select "Claim Credits Now." In the Clinic Episode 59: Weight Loss - CFPCLearn  

In episode 621, Tina, James and Mike K talk about the evidence around whole-body MRIs. We discuss how many abnormalities are found, how many cancers are actually found, and finally the lost opportunity costs. You need to know these numbers to talk to your patients about the value or lack thereof of doing this test. To claim your CPD credits, click the link below and then select "Claim Credits Now".  https://cfpclearn.ca/podcast/bs-medicine-episode-621-whole-body-mri-for-cancer-screening-many-findings-little-benefit/